| Withdrawn | Efficacy and Safety of Grass-SPIRE Registration Study Rhinitis, Conjunctivitis | Phase 2 / Phase 3 | 2016-05-01 |
| Completed | Birch-SPIRE Safety and Efficacy Study Rhinitis | Phase 2 | 2015-07-01 |
| Completed | Ragweed-SPIRE Follow-On Study Rhinoconjunctivitis, Ragweed Allergy | — | 2015-04-01 |
| Completed | Phase II HDM-SPIRE Safety and Efficacy Study Rhinoconjunctivitis | Phase 2 | 2014-09-01 |
| Completed | Grass Observational Study Grass Allergy, Rhinoconjunctivitis | — | 2014-04-01 |
| Completed | ToleroMune Grass Follow on Study Rhinoconjunctivitis, Grass Allergy | — | 2014-04-01 |
| Completed | Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma Seasonal Allergic Rhinitis, Asthma | Phase 2 | 2014-04-01 |
| Completed | Phase III Cat-PAD Follow-on Study Cat Allergy | Phase 3 | 2014-02-01 |
| Completed | Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure C Seasonal Allergic Rhinitis | Phase 2 | 2014-01-01 |
| Completed | Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and Asthma Seasonal Allergic Rhinitis, Asthma | Phase 2 | 2014-01-01 |
| Completed | ToleroMune House Dust Mite (HDM) Tolerability Study Rhinoconjunctivitis | Phase 2 | 2013-09-01 |
| Completed | House Dust Mite Observational Study Rhinoconjunctivitis | — | 2013-09-01 |
| Completed | An Optional Investigation of Biomarkers of Efficacy Rhinoconjunctivitis | — | 2013-09-01 |
| Completed | ToleroMune House Dust Mite Follow on Study House Dust Mite Allergy, Rhinoconjunctivitis | — | 2013-09-01 |
| Completed | Paediatric Safety Study in Cat-PAD Rhinoconjunctivitis | Phase 2 | 2013-08-01 |
| Completed | ToleroMune Grass Follow on Study Grass Allergy, Rhinoconjunctivitis | — | 2013-05-01 |
| Completed | Antipsoriatic Effect of a Topical Formulation for the Treatment of Psoriasis Vulgaris Psoriasis Vulgaris | Phase 1 | 2013-03-01 |
| Completed | Phase III Cat-PAD Study Rhinoconjunctivitis | Phase 3 | 2012-10-01 |
| Completed | An Optional Two Year Follow Up Study to Study CP005A Cat Allergy, Rhinoconjunctivitis | — | 2012-02-01 |
| Completed | ToleroMune Ragweed Follow up Study Ragweed Allergy, Rhinoconjunctivitis | — | 2011-10-01 |
| Completed | Identification of Potential Biomarkers of Peptide Immunotherapy. Part 2 - Gene Array Analysis Cat Allergy | Phase 1 | 2011-10-01 |
| Completed | Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis Cat Allergy | Phase 1 | 2011-10-01 |
| Completed | ToleroMune House Dust Mites (HDM) Exposure Chamber Study Rhinoconjunctivitis | Phase 2 | 2011-09-01 |
| Completed | ToleroMune Grass Exposure Unit Study Grass Allergy, Rhinoconjunctivitis | Phase 2 | 2011-08-01 |
| Completed | Ragweed Observational Study Ragweed Allergy | — | 2011-07-01 |
| Completed | Identification of Potential Biomarkers of Response to Peptide Immunotherapy for Ragweed Allergy Ragweed Allergy | Phase 2 | 2011-03-01 |
| Completed | Cat-PAD Follow on Study Cat Allergy, Rhinoconjunctivitis | — | 2011-02-01 |
| Completed | ToleroMune Ragweed Exposure Chamber Study Ragweed Allergy | Phase 2 | 2010-09-01 |
| Completed | Safety and Tolerability of ToleroMune Grass in Grass Allergic Subjects With Rhinoconjunctivitis Allergy | Phase 2 | 2010-07-01 |
| Completed | Cat-PAD Exposure Chamber Study Cat Allergy | Phase 2 | 2010-01-01 |
| Completed | Safety of ToleroMune House Dust Mite (HDM) to Treat House Dust Mite Allergy in HDM Allergic Subjects With Rhin Allergy | Phase 2 | 2009-11-01 |
| Completed | Safety of ToleroMune Ragweed to Treat Ragweed Allergy in Ragweed Allergic Subjects With Rhinoconjunctivitis Allergy | Phase 2 | 2009-04-01 |
| Completed | Safety of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects With Controlled Asthma Cat Allergy | Phase 2 | 2009-03-01 |
| Completed | Effectiveness of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects Cat Allergy | Phase 2 | 2008-08-01 |
| Completed | Safety of Cat-PAD in Cat Allergic Subjects Cat Allergy | Phase 1 / Phase 2 | 2008-01-01 |